Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anna Fagotti

Showing results (11-20 of 568) with videos related to

Pageof 57
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 6, 2022
Rucaparib Maintenance in Upfront Ovarian Cancer: The Long-Lasting Challenge of Predicting Response to Poly (ADP-ribose) Polymerase InhibitorsClaudia Marchetti, Anna Fagotti, Giovanni Scambia
American Journal of Obstetrics and Gynecology|September 22, 2019
ReplyStefano Uccella, Anna Fagotti, Giovanni Scambia
Gynecologic Oncology|July 18, 2006
Re: "Diagnostic open laparoscopy in the management of advanced ovarian cancer"Anna Fagotti, Francesco Fanfani, Giovanni Scambia
Comparative Biochemistry and Physiology. Part A, Molecular & Integrative Physiology|November 18, 2025
Heat shock protein 70 expression in the skin of Pelophylax bergeri in response to thermal stressFrancesca Simoncelli, Ines Di Rosa, Anna Fagotti
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 14, 2025
Reply to: Reflections on the HORSE Trial: Hyperthermic Intraperitoneal Chemotherapy, <i>BRCA</i> Status, and Clinical ImplicationsAnna Fagotti, Rita Trozzi, Diana Giannarelli, et al.
Current Opinion in Oncology|July 28, 2021
New developments in rare vulvar and vaginal cancersGiorgia Garganese, Alessia Romito, Giovanni Scambia, et al.
Expert Opinion on Drug Safety|October 6, 2018
The safety of bevazicumab for the treatment of ovarian cancerCarolina Bottoni, Giovanni Scambia, Anna Fagotti, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 1, 2022
How should randomized controlled trials in epithelial ovarian cancer be interpreted?Inge Peters, Andrea Rosati, Giovanni Scambia, et al.
Current Opinion in Obstetrics & Gynecology|July 1, 2014
Laparoendoscopic single-site hysterectomy: is it safe and feasible?Francesco Fanfani, Giorgia Monterossi, Anna Fagotti, et al.
American Journal of Obstetrics and Gynecology|July 3, 2010
Comparison of peritoneal carcinomatosis scoring methods in predicting resectability and prognosis in advanced ovarian cancerAnna Fagotti, Giuseppe Vizzielli, Francesco Fanfani, et al.
Pageof 57

Showing results (11-20 of 568) with videos related to

Sort By:
Pageof 57
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 6, 2022
Rucaparib Maintenance in Upfront Ovarian Cancer: The Long-Lasting Challenge of Predicting Response to Poly (ADP-ribose) Polymerase InhibitorsClaudia Marchetti, Anna Fagotti, Giovanni Scambia
American Journal of Obstetrics and Gynecology|September 22, 2019
ReplyStefano Uccella, Anna Fagotti, Giovanni Scambia
Gynecologic Oncology|July 18, 2006
Re: "Diagnostic open laparoscopy in the management of advanced ovarian cancer"Anna Fagotti, Francesco Fanfani, Giovanni Scambia
Comparative Biochemistry and Physiology. Part A, Molecular & Integrative Physiology|November 18, 2025
Heat shock protein 70 expression in the skin of Pelophylax bergeri in response to thermal stressFrancesca Simoncelli, Ines Di Rosa, Anna Fagotti
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 14, 2025
Reply to: Reflections on the HORSE Trial: Hyperthermic Intraperitoneal Chemotherapy, <i>BRCA</i> Status, and Clinical ImplicationsAnna Fagotti, Rita Trozzi, Diana Giannarelli, et al.
Current Opinion in Oncology|July 28, 2021
New developments in rare vulvar and vaginal cancersGiorgia Garganese, Alessia Romito, Giovanni Scambia, et al.
Expert Opinion on Drug Safety|October 6, 2018
The safety of bevazicumab for the treatment of ovarian cancerCarolina Bottoni, Giovanni Scambia, Anna Fagotti, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 1, 2022
How should randomized controlled trials in epithelial ovarian cancer be interpreted?Inge Peters, Andrea Rosati, Giovanni Scambia, et al.
Current Opinion in Obstetrics & Gynecology|July 1, 2014
Laparoendoscopic single-site hysterectomy: is it safe and feasible?Francesco Fanfani, Giorgia Monterossi, Anna Fagotti, et al.
American Journal of Obstetrics and Gynecology|July 3, 2010
Comparison of peritoneal carcinomatosis scoring methods in predicting resectability and prognosis in advanced ovarian cancerAnna Fagotti, Giuseppe Vizzielli, Francesco Fanfani, et al.
Pageof 57